CClinicalTrials.gg
RecruitingNCT07625761TOM1Updated Sep 21, 2026

Assessment of a New Tool to Measure Tongue Muscle Function

An interventional study of TOngue Manometer (TOM) device and IOPI in Healthy, sponsored by Université Catholique de Louvain. Recruiting at 1 site in Belgium. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by Université Catholique de Louvain · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
58
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The Iowa Oral Performance Instrument (IOPI) is currently the reference tool for assessing tongue muscle function, measuring the pressure exerted by the tongue on an air-filled bulb. However, several limitations reduce its precision and clinical relevance. To overcome these, the TOngue Manometer (TOM) has been developed. This crossover study compares the two devices in healthy adults, hypothesizing that the TOM's interface will enable participants to produce higher maximal tongue pressure and endurance values, closer to their ground truth.

02

Conditions studied

  • Healthy

Keywords

  • Adults
  • Healthy
  • tongue
  • muscles
03

In context

Lead sponsor

Université Catholique de Louvain is the lead sponsor of 144 studies on the registry; 57 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Being a healthy adult aged 18 to 65 years old
  • Being able to understand and speak French

Exclusion criteria

Exclusion Criteria:

  • Being diagnosed with a cardiorespiratory or neuromuscular disease
  • Being diagnosed with obstructive sleep apnea-hypopnea syndrome
  • Any reason preventing the participant from completing the measurement protocol (e.g., oral pain, severe cognitive impairment, lack of cooperation, illiteracy)
  • Being involved in an oropharyngeal rehabilitation program
  • Having dysphagia
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
58 participants (estimated)

Study arms

  • Experimental
    TOM session

    Device: TOngue Manometer (TOM) device

  • Active comparator
    IOPI session

    Device: IOPI

Interventions

  • DeviceTOngue Manometer (TOM) device

    New, lab-made device

  • DeviceIOPI

    The device currently identified as gold standard for tongue muscles assessment

06

What researchers measure

Primary outcomes

  1. Tongue Pmax in elevation (pElev)

    Tongue maximal pressure (kPa) in elevation, either with the TOM or the IOPI, depending on the visit and the randomization order

    Time frame: Throughout the entire study, approximately during 14 months

  2. Tongue endurance in elevation (eElev)

    Endurance time (sec.), i.e., time during which the tongue can sustain 50% of its Pmax in elevation, measured either with the TOM or the IOPI, depending on the visit and the randomization order

    Time frame: Throughout the entire study, approximately during 14 months

Secondary outcomes

  1. Body mass index (kg/m^2)

    Time frame: Throughout the entire study, approximately during 14 months

  2. Mouth, tongue, and face assessment test (through MBLF test)

    This test (MBLF test, for 'test de motricité bucco-linguo-faciale') features an assessment of several muscles (e.g., lips, tongue, and face area) that are assessed on a scale from 0 (no contraction / severe asymmetry) to 3 (normal contraction / complete symmetry).

    Time frame: Throughout the entire study, approximately during 14 months

  3. Mouth breathing questionnaire

    A score 0-3 suggests high likelihood of habitual nose breathing; 4-7 a suspicion of mouth breathing; 8 or higher a high likelihood of habitual mouth breathing

    Time frame: Throughout the entire study, approximately during 14 months

  4. Tongue thickness (POCUS)

    A submental and neck ultrasound will be performed to assess tongue muscles thickness (cm)

    Time frame: Throughout the entire study, approximately during 14 months

07

Study locations

1 of 1 sites recruiting
  • Institut de Recherche Expérimentale et Clinique (IREC) - UCLouvain; Lung, Nose, and Skin (LUNS) lab
    Brussels, 1200, Belgium
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07625761
Lead sponsor
Université Catholique de Louvain
Responsible party
Sponsor
First posted
Jun 4, 2026
Start date
Jun 4, 2026
Primary completion
Aug 1, 2027 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Sep 21, 2026

Study contacts

Pierre Cnockaert, MSc
Contact
pierre.cnockaert@outlook.com
+32478136109
William Poncin, PhD
study chair · Université Catholique de Louvain

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion